277 related articles for article (PubMed ID: 31954196)
1. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
Hu B; Qiu Y; Hong J
Ocul Surf; 2020 Apr; 18(2):298-304. PubMed ID: 31954196
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.
Shen Z; Ma J; Peng R; Hu B; Zhao Y; Liu S; Hong J
Transplant Cell Ther; 2022 Nov; 28(11):749.e1-749.e7. PubMed ID: 35914728
[TBL] [Abstract][Full Text] [Related]
3. Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.
Serapicos P; Kim C; Barros SL; Mendes Silva Jordão IMB; Hiyane MI; Barbosa de Sousa L; Zecchin VG; Camara NOS; de Oliveira LA
Ocul Immunol Inflamm; 2023 May; 31(4):701-709. PubMed ID: 35404738
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.
Singh RB; Yung A; Coco G; Sinha S; Dohlman TH; Yin J; Dana R
Ocul Surf; 2020 Oct; 18(4):731-735. PubMed ID: 32738300
[TBL] [Abstract][Full Text] [Related]
5. Tear Cytokines as Biomarkers for Acute Ocular Graft-Versus-Host Disease.
Qiu Y; Hu B; Peng RM; Huang JF; Hong J
Cornea; 2022 Nov; 41(11):1405-1411. PubMed ID: 35184125
[TBL] [Abstract][Full Text] [Related]
6. Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients.
Nair S; Vanathi M; Mahapatra M; Seth T; Kaur J; Velpandian T; Ravi A; Titiyal JS; Tandon R
Ocul Surf; 2018 Jul; 16(3):352-367. PubMed ID: 29723628
[TBL] [Abstract][Full Text] [Related]
7. Tear Osmolarity and Ocular Surface Parameters as Diagnostic Markers of Ocular Graft-Versus-Host Disease.
Na KS; Yoo YS; Hwang KY; Mok JW; Joo CK
Am J Ophthalmol; 2015 Jul; 160(1):143-9.e1. PubMed ID: 25870935
[TBL] [Abstract][Full Text] [Related]
8. Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
Pietraszkiewicz AA; Payne D; Abraham M; Garced A; Devarasetty KC; Wall M; Menezes SM; Ugarte S; Pirsl F; Goklemez S; Ferris FL; Barrett J; Battiwalla M; Childs RW; Pavletic SZ; Bishop RJ
Bone Marrow Transplant; 2021 Aug; 56(8):1850-1858. PubMed ID: 33686249
[TBL] [Abstract][Full Text] [Related]
9. Tear Cytokines Associated With Therapeutic Effects in Chronic Ocular Graft-Versus-Host Disease.
Ma J; Shen Z; Peng R; Li C; Zhao Y; Hu B; Hong J
Cornea; 2023 Feb; 42(2):211-216. PubMed ID: 36582034
[TBL] [Abstract][Full Text] [Related]
10. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
Jung JW; Han SJ; Song MK; Kim TI; Kim EK; Min YH; Cheong JW; Seo KY
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2079-2085. PubMed ID: 26303101
[TBL] [Abstract][Full Text] [Related]
11. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
[TBL] [Abstract][Full Text] [Related]
12. Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy.
Wang S; Singh RB; Yuksel E; Musayeva A; Sinha S; Taketani Y; Dohlman TH; Dana R
Ocul Surf; 2022 Oct; 26():142-147. PubMed ID: 35948166
[TBL] [Abstract][Full Text] [Related]
13. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
Chen Y; Mallem K; Asbell PA; Ying GS
Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.
Riemens A; Stoyanova E; Rothova A; Kuiper J
Mol Vis; 2012; 18():797-802. PubMed ID: 22509110
[TBL] [Abstract][Full Text] [Related]
15. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
[TBL] [Abstract][Full Text] [Related]
16. Tear osmolarity in ocular graft-versus-host disease.
Berchicci L; Iuliano L; Miserocchi E; Bandello F; Modorati G
Cornea; 2014 Dec; 33(12):1252-6. PubMed ID: 25343699
[TBL] [Abstract][Full Text] [Related]
17. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
[TBL] [Abstract][Full Text] [Related]
18. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
[TBL] [Abstract][Full Text] [Related]
19. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
20. Assessment of dry eye in a GVHD murine model: Approximation through tear osmolarity measurement.
Martínez-Carrasco R; Sánchez-Abarca LI; Nieto-Gómez C; García EM; Ramos TL; Velasco A; Sánchez-Guijo F; Aijón J; Hernández-Galilea E
Exp Eye Res; 2017 Jan; 154():64-69. PubMed ID: 27818317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
